Efficacy allogeneic hematopoietic stem cell transplantation with different conditioning regimens in pediatric myelodysplastic syndrome
https://doi.org/10.17650/2311-1267-2017-4-2-70-77
Abstract
About the Authors
A. A. OsipovaRussian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
E. V. Semenova
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
E. V. Morozova
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
T. A. Bykova
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
V. N. Ovechkina
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
A. S. Borovkova
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
P. V. Kozhokar
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
O. V. Paina
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
S. V. Razumova
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
E. V. Babenko
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
A. L. Alyanskiy
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
T. L. Gindina
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
I. M. Barkhatov
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
B. I. Smirnov
Russian Federation
5 Professor Popov St., Saint Petersburg, 197376
L. S. Zubarovskaya
Russian Federation
6–8 L’va Tolstogo St., Saint Petersburg, 197022
B. V. Afanasiev
Russian Federation
References
1. Vardiman J., Thiele J., Arber D. et al. The 2008 revision of the WHO classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009;114:947–51.
2. Arber D.A., Orazi A., Hasserjian R. et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016;127(20):2391–405.
3. Hasle H., Baumann I., Bergstrasser E. et al. International prognostic scoring system (IPSS) for childhood MDS and JMML. Blood 2001;98:624a.
4. Hasle H. Myelodysplastic and myeloproliferative disorders of childhood. Hematology Am Soc Hematol Educ Program 2016;2016(1):598–604.
5. Hirabayashi S., Floto C., Mooetter J. et al. European Working Group of MDS in Childhood. Spliceosomal gene aberrations are rare, coexist with oncoggenic mutations, and are unlikely to evert a driver effect in childhood MDS and JMML. Blood 2012;119(11):e96–e99.
6. Sureda A., Bader P., Cesaro S. et al. Indications for allo- and auto-SCT for hematological diseases, solid tumors and immune disorders: current practice in Europe, 2015. Bone Marrow Transplant 2015;50(8):1037–56.
7. Strahm B., Nollke P., Zecca M. et al. EWOG-MDS study group. Hematopoietic stem cell transplantation for advanced myelodisplastic syndrome in children: results of the EWOG-MDS 98 study. Lukemia 2011;25(3):455–62.
8. Locatelli F., Nollke P., Zecca M. et al. Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994;8(5):844–9.
9. Locatelli F., Nollke P., Zecca M. et al. Hematopoietic stem cell transplantation in children with juvenile myelomonocytic leukemia: results of the EWOG-MDS/EBMT trial. Blood 2005;105(1):410–9.
10. Strahm B., Locatelli F., Bader P. et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 2007;40(4):329–33.
11. Woodard P., Carpenter P., Davies S. et al. Unrelated donor bone marrow transplantation for myelodysplastic syndrome in children. Biol Blood Marrow Transplant 2011;17(5):723–8.
12. Семенова Е.В., Станчева Н.В., Алянский А.Л. и др. Аллогенная трансплантация гемопоэтических стволовых клеток с режимами кондиционирования со сниженной интенсивностью доз у детей и подростков с прогностически неблагоприятными формами острого лимфобластного лейкоза. Онкогематология 2011;6(4):19–26. [Semenova E.V., Stancheva N.V., Alyanskiy A.L. et al. Allogeneic hematopoietic stem cells transplantation with reduced intensity conditioning regimen in children and adolescents with unfavorable forms of acute lymphoblastic leukemia. Onkogematologiya = Oncohematology 2011;6(4):19–26. (In Russ.)].
13. Hasle H., Niemeyer C.M. Advances in the prognostication and management of advanced MDS in children. Br J Haematol 2011;154(2):185–95.
Review
For citations:
Osipova A.A., Semenova E.V., Morozova E.V., Bykova T.A., Ovechkina V.N., Borovkova A.S., Kozhokar P.V., Paina O.V., Razumova S.V., Babenko E.V., Alyanskiy A.L., Gindina T.L., Barkhatov I.M., Smirnov B.I., Zubarovskaya L.S., Afanasiev B.V. Efficacy allogeneic hematopoietic stem cell transplantation with different conditioning regimens in pediatric myelodysplastic syndrome. Russian Journal of Pediatric Hematology and Oncology. 2017;4(2):70-77. (In Russ.) https://doi.org/10.17650/2311-1267-2017-4-2-70-77